A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: once (1000)

Knee strengthening exercises - patient information

Description
This factsheet contains exercises to help strengthen your knee.
Url
/Media/UHS-website-2019/Patientinformation/Medicinestherapiesandanaesthetics/Knee-strengthening-exercises-3923-PIL.pdf

Your hepatitis C treatment - Zepatier® - patient information

Description
This factsheet explains how hepatitis C is treated with a medication called Zepatier®.
Url
/Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Hepatology/Your-hepatitis-C-treatment-Zepatier®-1595-PIL.pdf

Maviret for hepatitis C - patient information

Description
Maviret® is a combination tablet that contains two drugs (Glecaprevir 100mg and Pibrentasvir 40mg).It is used to treat Hepatitis C
Url
/Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Hepatology/Maviret-for-hepatitis-C-1769-PIL.pdf

Your hepatitis C treatment (Epclusa with/without Ribavirin) - patient information

Description
You are starting a course of Epclusa® with/without ribavirin to treat your hepatitis C infection. These medications are taken in
Url
/Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Hepatology/Your-hepatitis-C-treatment-Epclusa-withwithout-Ribavirin-1621-PIL.pdf

Hepatitis C - Harvoni® with or without ribavirin - patient information

Description
Patient information factsheet Your hepatitis C treatment Harvoni® We have given you this factshe
Url
/Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Hepatology/Hepatitis-C-Harvoni®-with-or-without-ribavirin-1258-PIL.pdf

SMILE

Description
Chemotherapy Protocol LYMPHOMA PEGAPARGASE-DEXAMETHASONE-ETOPOSIDE-IFOSFAMIDE-METHOTREXATE (SMILE) Inpatient Regimen Regime
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/SMILE-Ver1.pdf

Epcoritamab -Cycle 2 (Onwards)

Description
Chemotherapy Protocol LYMPHOMA EPCORITAMAB – Cycle 2 Onwards - (28 day) Regimen • Lymphoma-Epcoritamab – Cycle 2 Onwards - (28 day
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Epcoritamab-Cycle-2-Onwards-Ver1.pdf

Epcoritamab -Cycle 1 (Priming)

Description
Chemotherapy Protocol LYMPHOMA EPCORITAMAB -Cycle 1 - (28 Day -Priming) Regimen • Lymphoma-Epcoritamab – Cycle 1- (2
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Epcoritamab-Cycle-1-Priming-Ver1.pdf

AtezolizumabSC Bevacizumab Carboplatin Paclitaxel

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) ATEZOLIZUMAB-SC-BEVACIZUMAB-CARBOPLATIN (AUC6)-PACLITAXEL R
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/AtezolizumabSC-Bevacizumab-Carboplatin-Paclitaxel-Ver1.0.pdf

National maternity survey 2024 - UHS NHS FT benchmarking report

Description
NHS Maternity Services Survey 2024 Benchmark Report University Hospital Southampton NHS Foundation Trust 1 Maternity Survey 2024 | RH
Url
/Media/UHS-website-2019/Docs/Services/Maternity/National-maternity-survey-2024-UHS-NHS-FT-benchmarking-report.pdf
411 to 420 of 1000
Previous … 40 41 42 43 44 … Next